Papers
3
Total Citations
135
H-Index
3
About
Dr. Nicolas Zhou is a leading thoracic surgeon and researcher whose work sits at the intersection of surgical oncology, immunotherapy, and health services research. His most impactful contributions center on optimizing multimodal treatment for non-small cell lung cancer (NSCLC), particularly through the integration of neoadjuvant immunotherapy. In a landmark 2022 study, Zhou demonstrated that combining nivolumab with ipilimumab before surgery yields promising pathological responses in NSCLC patients, a finding that has garnered 94 citations and helped shape evolving perioperative protocols. He has also advanced the field of minimally invasive thoracic surgery, publishing a pivotal 2021 analysis of robotic-assisted anatomic segmentectomy that tracked national trends and patient selection criteria. Beyond technical innovation, Zhou investigates patient-centered outcomes, as evidenced by his 2023 study on surgical approach and persistent opioid use among Medicare beneficiaries undergoing lung cancer resection. With a growing bibliography that bridges cutting-edge immunotherapy, precision surgery, and real-world outcomes, Zhou is recognized as a thoughtful voice in the next generation of thoracic oncology research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3